Severe Bronchoconstriction Caused by Administration of Rocuronium in a 3-Month-Old Infant: Case Report - 17/12/20
Doi : 10.1016/j.jpeds.2020.08.031
Nicolle F. Dyess, MD 1, ⁎ 
, Megan L. Albertz, MD 2, Michael E. Murphy, PharmD 3, John P. Kinsella, MD 1
, Megan L. Albertz, MD 2, Michael E. Murphy, PharmD 3, John P. Kinsella, MD 1 1 Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO
2 Section of Anesthesiology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO
3 Department of Pharmacy, Children's Hospital Colorado, Aurora, CO
∗Reprint requests: Nicolle F. Dyess, MD, Department of Pediatrics, Section of Neonatology, University of Colorado Denver, 13121 East 17th Ave, Mail Stop 8402, Room 4304, Aurora, CO 80045Department of PediatricsSection of NeonatologyUniversity of Colorado Denver13121 East 17th AveMail Stop 8402Room 4304AuroraCO80045
Abstract |
We present the case of a 3-month-old infant with severe, persistent bronchoconstriction following administration of rocuronium. This observation raises awareness of a rare but potentially life-threatening reaction to neuromuscular blocking agents.
Le texte complet de cet article est disponible en PDF.Keywords : anaphylaxis, neuromuscular blocking agent, case report, pediatrics
Abbreviations : NMBA, PDA
Plan
| J. K. Supported by NIH/NCATS Colorado CTSA (UL1 TR002535). The authors declare no conflicts of interest. |
© 2020
Elsevier Inc. Tous droits réservés.
Vol 228
P. 297-300 - janvier 2021 Retour au numéro
Article précédent
- Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients
- Alexander M. Newman, Ravi Jhaveri, Ami B. Patel, Tina Q. Tan, Jacqueline M. Toia, Mehreen Arshad
- Recurrent Facial Palsy in a Teenager
- Maria Angeli, Eleni Vergadi, Ioannis Tsiverdis, Vasileios Mastorodemos, Emmanouil Galanakis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?